Venous thromboembolism in children

Circulation

Volumn 113, Issue 2, 2006, Pages

  Parasuraman, Sudha ^a   Goldhaber, Samuel Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; ARGATROBAN; ASPARAGINASE; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; D DIMER; ENOXAPARIN; ESTROGEN; FIBRINOLYTIC AGENT; HEPARIN; HOMOCYSTEINE; LEPIRUDIN; LIPOPROTEIN A; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN C; PROTEIN S; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ANTICOAGULANT THERAPY; ANTITHROMBIN III DEFICIENCY; BLEEDING; CANCER CHEMOTHERAPY; CASE REPORT; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD LEUKEMIA; CLINICAL PRACTICE; COMORBIDITY; COMPRESSION THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG INFORMATION; DRUG MEGADOSE; DRUG SAFETY; ECHOCARDIOGRAPHY; ESTROGEN THERAPY; FEMALE; GENE MUTATION; HEPARIN INDUCED THROMBOCYTOPENIA; HIGH RISK PATIENT; HUMAN; LUNG EMBOLISM; LUNG SCINTISCANNING; LUNG VENTILATION PERFUSION RATIO; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PATIENT MONITORING; POSTTHROMBOSIS SYNDROME; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; REVIEW; RISK FACTOR; TALL STATURE; VENOUS THROMBOEMBOLISM; THROMBOEMBOLISM; VEIN THROMBOSIS;

ANTICOAGULANTS; CHILD; HUMANS; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 33645004929     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.583773     Document Type: Review

References (35)

1. Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, Bernstein M, Brisson L, Cairney B, DeSai D. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994;83:1251-1257.
2. van Ommen CH, Heijboer H, Bãler HR, Hirasing RA, Heijmans HS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands. J Pediatr. 2001;139:676-681.
3. Nowak-Gottl U, von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed. 1997;76:F163-F167.
4. Stein PD, Kayali F, Olson RE. Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey. J Pediatr. 2004;145: 563-565.
5. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics. 1995;96: 939-943.
6. Male C, Chait P, Andrew M, Hanna K, Julian J, Mitchell L. Central venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood. 2003;101:4273-4278.
7. McLean TW, Fisher CJ, Snively BM, Chauvenet AR. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement. J Clin Oncol. 2005;23:3024-3029.
8. Athale UH, Chan AK. Thrombosis in children with acute lymphoblastic leukemia, part I: epidemiology of thrombosis in children with acute lymphoblastic leukemia. Thromb Res. 2003;111:125-131.
9. Tabori U, Beni-Adani L, Dvir R, Burstein Y, Feldman Z, Pessach I, Rechavi G, Constantini S, Toren A. Risk of venous thromboembolism in pediatric patients with brain tumors. Pediatr Blood Cancer. 2004;43:633-636.
10. Deitcher SR, Gajjar A, Kun L, Heideman RL. Clinically evident venous thromboembolic events in children with brain tumors. J Pediatr. 2004;145:848-850.
11. Wermes C, von Depka Prondzinski M, Lichtinghagen R, Barthels M, Welte K, Sykora KW. Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters. Eur J Pediatr. 1999;158(suppl 3):S143-S146.
12. Sifontes MT, Nuss R, Hunger SP, Wilimas J, Jacobson LJ, Manco-Johnson MJ. The factor V Leiden mutation in children with cancer and thrombosis. Br J Haematol. 1997;96: 484-489.
13. van Ommen CH, Fijnvandraat K, Vulsma T, Delemarre-Van De Waal HA, Peters M. Acquired protein S deficiency caused by estrogen treatment of tall stature. J Pediatr. 1999;135:477-481.
14. Manco-Johnson MJ, Nuss R, Key N, Moertel C, Jacobson L, Meech S, Weinberg A, Lefkowitz J. Lupus anticoagulant and protein S deficiency in children with post-varicella purpura fulminans or thrombosis. J Pediatr. 1996;128:319-323.
15. Schlegel N. Thromboembolic risks and complications in nephrotic children. Semin Thromb Hemost. 1997;23:271-280.
16. Monagle P, Karl TR. Thromboembolic problems after the Fontan operation. Semin Thorac Cardiovas Surg. 2002;5:36-47.
17. Young G, Driscoll MC. Coagulation abnormalities in the carbohydrate-deficient glycoprotein syndrome: case report and review of the literature. Am J Hematol. 1999;60: 66-69.
18. Streif W, Andrew ME. Venous thromboembolic events in pediatric patients: diagnosis and management. Hematol Oncol Clin North Am. 1998;12:1283-1312.
19. Andrew M, Monagle P, Brooker LA. Congenital prothrombotic disorders: presentation during infancy and childhood. In: Thromboembolic Complications During Infancy and Childhood, 2000 Edition. Hamilton, BC, Canada: Decker; 2000:47-110.
20. Hagstrom JN, Walter J, Bluebond-Langner R, Amatniek JC, Manno CS, High KA. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr. 1998;133:777-781.
21. Vielhaber H, Ehrenforth S, Koch HG, Scharrer I, van der Werf N, Nowak-Gottl U. Cerebral venous sinus thrombosis in infancy and childhood: role of genetic and acquired risk factors of thrombophilia. Eur J Pediatr. 1998;157:555-560.
22. Gurgey A, Aslan D. Outcome of noncatheter-related thrombosis in children: influence of underlying or coexisting factors. J Pediatr Hematol Oncol. 2001;23:159-164.
23. Monagle P, Adams M, Mahoney M, Ali K, Barnard D, Bernstein M, Brisson L, David M, Desai S, Scully MF, Halton J, Israels S, Jardine L, Leaker M, McCusker P, Silva M, Wu J, Anderson R, Andrew M, Massicotte MP. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res. 2000;47:763-766.
24. Nowak-Gottl U, Junker R, Kreuz W, von Eckardstein A, Kosch A, Nohe N, Schobess R, Ehrenforth S. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood. 2001;97: 858-862.
25. Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med. 2004;351:1081-1088.
26. van Ommen CH, Heijboer H, van den Dool EJ, Hutten BA, Peters M. Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome. J Thromb Haemost. 2003; 1:2516-2522.
27. Manco-Johnson MJ, Nuss R, Hays T, Krupski W, Drose J, Manco-Johnson ML. Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. J Pediatr. 2000;136:446-1453.
28. Schoepf UJ, Goldhaber SZ, Costello P. Spiral computed tomography for acute pulmonary embolism. Circulation. 2004;109:2160-2167.
29. Male C, Kuhle S, Mitchell L. Diagnosis of venous thromboembolism in children. Semin Thromb Hemost. 2003;29:377-390.
30. Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:645S-687S.
31. Ignjatovic V, Barnes C, Newall F, Hamilton S, Burgess J, Monagle P. Point of care monitoring of oral anticoagulant therapy in children: comparison of CoaguChek Plus and Thrombotest methods with venous international normalised ratio. Thromb Haemost. 2004;92:734-737.
32. Manco-Johnson MJ, Grabowski EF, Hellgreen M, Kemahli As, Massicotte MP, Muntean W, Peters M, Schlegel N, Wang M, Nowak-Gattl U, on behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Recommendations for tPA thrombolysis in children. Thromb Haemost. 2002;88:157-158.
33. Klenner AF, Lubenow N, Raschke R, Greinacher A. Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature. Thromb Haemost. 2004;91:719-724.
34. Risch L, Fischer JE, Herklotz R, Huber AR. Heparin-induced thrombocytopenia in paediatrics: clinical characteristics, therapy and outcomes. Intensive Care Med. 2004;30:1615-1624.
35. Kucher N, Quiroz R, McKean S, Sasahara AA, Goldhaber SZ. Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism. Vasc Med. 2005;10:251-266.